Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma

Urology

Volumn 64, Issue 3, 2004, Pages 617-621

  Inoue, Takamitsu ^a   Sato, Kazunari ^a   Tsuchiya, Norihiko ^a   Matsuura, Shinobu ^a   Iinuma, Masahiro ^a   Habuchi, Tomonori ^a   Kato, Tetsuro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PARAFFIN;

AGED; ARTICLE; CANCER; CANCER DIAGNOSIS; CARCINOMA IN SITU; CENTROMERE; CHROMOSOME 17; CYTOLOGY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; TISSUE SECTION; URINE;

AGED; ANEUPLOIDY; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CENTROMERE; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PARAFFIN EMBEDDING; URINE; UROLOGIC NEOPLASMS;

EID: 4444323178     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.05.004     Document Type: Article

References (19)

1. Boman H., Hedelin H., Holmang S. Four bladder tumor markers have a disappointingly low sensitivity for small size and low-grade recurrence. J Urol. 167:2002;80-83
2. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 164:2000;1768-1775
3. Schechter A.L., Stern D.F., Vaidyanathan L., et al. The neu oncogene an erb-B related gene encoding 185,000-M tumor antigen. Nature. 312:1984;513-516
4. Yonemura Y., Ninomiya I., Ohoyama S., et al. Expression of c-erbB2 protein in gastric carcinoma immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer. 67:1991;2914-2918
5. Slamon D.J., Godolphin W., Jones L.A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244:1989;707-712
6. Sato K., Moriyama M., Mori S., et al. An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer. 70:1992;2493-2498
7. Coombs L.M., Pigott D.A., Sweeney E., et al. Amplification and over-expression of c-erbB2 in transitional cell carcinoma of the urinary bladder. Br J Cancer. 63:1991;601-608
8. Habuchi T., Kinoshita H., Yamada H., et al. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J Natl Cancer Inst. 86:1994;1331-1335
9. Lonn U, Lonn S, Friberg S, et al. Prognostic value of amplification of c-erb-B2 in bladder carcinoma. Clin Cancer Res 1: 1189-1194, 1995
10. Underwood M., Bartlett J., Reeves J., et al. C-erbB-2 gene amplification a molecular marker in recurrent bladder tumors? Cancer Res. 55:1995;2422-2430
11. Ohta J, Miyoshi Y, Uemura H, et al. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer. Clin Cancer Res 7: 2463-2467, 2001
12. Sauter G., Moch H., Moore D., et al. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res. 53:1993;2199-2203
13. Simon R., Atefy R., Wagner U., et al. HER-2 and TOP2A coamplification in urinary bladder cancer. Int J Cancer. 107:2003;764-772
14. The Japanese Urological Association and Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Bladder Cancer. 3rd ed:2001;Kanahara-Shuppan, Tokyo
15. The Japanese Urological Association and Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Renal Pelvic and Ureteral Cancer. 2nd ed:2002;Kanahara-Shuppan, Tokyo
16. Sato K., Qian J., Slezak M.J., et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst. 91:1999;1574-1580
17. Takahashi K., Habuchi T., Kakehi Y., et al. Clonal and chronological analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res. 58:1998;5835-5841
18. Kruger S., Mess F., Bohle A., et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder. Int J Oncol. 23:2003;41-48
19. Riddle P.R., Chisholm G.D., Trott P.A., et al. Flat carcinoma in situ of the bladder. Br J Urol. 47:1976;829